Allogene Therapeutics Inc

ALLO

Add to Watchlist

2.000USD

+0.040+2.04%

Close 06/18, 16:00（ET）Quotes delayed by 15 min

489.63MMarket Cap

LossP/E TTM

Allogene Therapeutics Inc

2.000

+0.040+2.04%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-06-18

Previous score

3.00

Change

The current institutional shareholding score of Allogene Therapeutics Inc is 3.00, ranking 193 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 44.66%, representing a quarter-over-quarter decrease of 45.84%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.87% of shares outstanding, with 40.37% increase in holdings.